(52 days)
K 023503, K 982521
Not Found
No
The device description and performance studies focus on the physical and electrical properties of the ECG electrodes, with no mention of AI or ML for data analysis or interpretation.
No
The device is described as being for "general electrocardiographic procedures where ECG monitoring is deemed necessary and is ordered by a physician," and specifically for "patient ECG surveillance and ECG diagnosis recording," which are diagnostic rather than therapeutic purposes.
Yes
The "Intended Use / Indications for Use" states that the electrodes are for "ECG diagnosis recording" and the "Device Description" states they are "for diagnostic resting ECG".
No
The device description explicitly states that the device is composed of physical components like PET tape, Ag/AgCl ink, and conductive gel, and is a self-adhesive, non-sterile, single-use disposable electrode. This indicates it is a hardware device, not software-only.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use clearly states the electrodes are for "general electrocardiographic procedures where ECG monitoring is deemed necessary and is ordered by a physician." This involves measuring electrical signals from the body's surface, not analyzing samples taken from the body (like blood, urine, or tissue).
- Device Description: The description details the physical components of the electrode and its function in conducting electrical signals. There is no mention of reagents, assays, or any components used for analyzing biological samples.
- Lack of IVD Characteristics: The document does not mention any of the typical characteristics of an IVD, such as:
- Analyzing biological samples (blood, urine, etc.)
- Detecting specific substances or markers within those samples
- Providing diagnostic information based on the analysis of samples
The device is an external medical device used for physiological monitoring (ECG).
N/A
Intended Use / Indications for Use
Skintact ECG electrodes are designed for use in general electrocardiographic procedures where ECG monitoring is deemed necessary and is ordered by a physician. Such procedures include in particular, patient ECG surveillance and ECG diagnosis recording. Skintact ECG electrodes are non-sterile and are to be used on intact (uninjured) skin.
Product codes (comma separated list FDA assigned to the subject device)
DRX
Device Description
Skintact® ECG Tab Electrodes (and as also to be offered for sale under various private label tradenames) will be offered with LecTec LT 4900 gel. Skintact ECG Tab Electrodes with LecTec LT 4900 gel are self-adhesive, non-sterile, single use disposable electrodes for diagnostic resting ECG. ECG Tab electrodes are composed of a PET tape, Ag/AgCl ink and a conductive gel, at each case 10 electrodes are applied on a one-sided siliconized transparent PET card, 10 cards are packaged in a pouch.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Biocompatibility testing confirms the materials are biocompatible and do not introduce any risks. The following testing showed no adverse results: Cytotoxicity; Skin Irritation; Sensitization.
The ANSI/AAMI EC 12:2000 "Disposable ECG electrodes" was used to define the requirements for Skintact ECG Tab Electrodes with LecTec LT 4900 gel. All electrical tests are according to ANSUAAMI EC 12:2000. The testing conducted was: AC impedance: DC offset voltage: Defibrillation overload recovery; Combined offset instability and internal noise; Bias current tolerance. The shelf life of the electrodes was tested in real-time aging.
Clinical data: Three ECG tracings using LecTec LT 4900 gel electrodes were provided. Each tracing contains more than 10 seconds of data. The data demonstrate that ECG Tab electrodes with LecTec LT 4900 gel provide a reliable signal tracing of consistent high quality.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Tracet Ag 4000 electrodes by LecTec Corporation, K 023503, K 982521
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 870.2360 Electrocardiograph electrode.
(a)
Identification. An electrocardiograph electrode is the electrical conductor which is applied to the surface of the body to transmit the electrical signal at the body surface to a processor that produces an electrocardiogram or vectorcardiogram.(b)
Classification. Class II (special controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 870.9. The special control for this device is the FDA guidance document entitled “Class II Special Controls Guidance Document: Electrocardiograph Electrodes.” See § 870.1(e) for availability information of guidance documents.
0
JAN 1 6
510(k) Summary
SUBMITTED ON BEHALF OF:
| Company Name: | Leonhard Lang GmbH |
|---|---|
| Address: | Archenweg 56 |
| 6010 Innsbruck | |
| Austria | |
| Telephone: | ++ 43 / 512 / 33 4 25 7 |
| Fax: | ++ 43 / 512 / 39 22 10 |
by:
Elaine Duncan, MS.M.E., RAC President, Paladin Medical, Inc. PO Box 560 Stillwater, MN 55082 715-549-6035 715-549-5380
Telephone: Fax:
Elaine Duncan
DATE PREPARED:
CONTACT PERSON:
Trade Name: Common Name: Classification Name: Skintact® ECG Tab Electrode Disposable ECG Electrodes
November 21, 2002
Electrocardiograph (ECG) electrode
Skintact® ECG Tab Electrodes with LecTec LT 4900 SUBSTANTIALLY EQUIVALENT TO: gel are substantially equivalent to the Tracet Ag 4000 electrodes by LecTec Corporation. Leonhard Lang has predicate ECG electrodes (same procode) of different materials and construction design cleared in previous 510(k) submissions such as K 023503 and K 982521.
DESCRIPTION of the DEVICE: Skintact® ECG Tab Electrodes (and as also to be offered for sale under various private label tradenames) will be offered with LecTec LT 4900 gel. Skintact ECG Tab Electrodes with LecTec LT 4900 gel are self-adhesive, non-sterile, single use disposable electrodes for diagnostic resting ECG. ECG Tab electrodes are composed of a PET tape, Ag/AgCl ink and a conductive gel, at each case 10 electrodes are applied on a one-sided siliconized transparent PET card, 10 cards are packaged in a pouch.
INDICATIONS FOR USE:
Skintact ECG electrodes are designed for use in general electrocardiographic procedures where ECG monitoring is deemed necessary and is ordered by a physician. Such procedures include in particular patient ECG surveillance and ECG diagnosis recording. Skintact ECG electrodes are non-sterile and are to be used on intact (uninjured) skin. (NO CHANGE to ORIGINAL INDICATION for USE previously cleared by Leonhard Lang.)
SUMMARY of TESTING:
Biocompatibility testing confirms the materials are biocompatible and do not introduce any risks. The following testing showed no adverse results: Cytotoxicity; Skin Irritation; Sensitization.
510(k): ECG Tab Electrodes with Lectec LT 4900 Gel
1
510(k) Summary-Continued
The ANSI/AAMI EC 12:2000 "Disposable ECG electrodes" was used to define the requirements for Skintact ECG Tab Electrodes with LecTec LT 4900 gel. All electrical tests are according to ANSUAAMI EC 12:2000. The testing conducted was: AC impedance: DC offset voltage: Defibrillation overload recovery; Combined offset instability and internal noise; Bias current tolerance. The shelf life of the electrodes was tested in real-time aging.
Leonhard Lang has experience for about 20 years of using the current packaging and this ensures all requirements for the 24 months shelf-life of the electrodes.
The comparison with the predicate device and the data from the ECG Tab electrodes with LecTec LT 4900 gel shows similar results. The difference is negligible in the limits defined in ANSVAAMI EC12:2000. Therefore the electrical performance of the predicate device and ECG Tab electrodes with LecTec LT 4900 gel is equivalent.
Clinical data: Three ECG tracings using LecTec LT 4900 gel electrodes were provided. Each tracing contains more than 10 seconds of data. The data demonstrate that ECG Tab electrodes with LecTec LT 4900 gel provide a reliable signal tracing of consistent high quality.
2
Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo features a stylized caduceus, which is a symbol often associated with medicine and healthcare. The caduceus is depicted with three intertwined strands, representing the department's commitment to health, well-being, and human services. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES • USA" is arranged in a circular fashion around the caduceus.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
JAN 1 6 2003
Leonhard Lang GmbH c/o Ms. Elaine Duncan Paladin Medical, Inc. P.O. Box 560 Stillwater, MN 55082-0560
Re: K023920
Skintact® ECG Tab Electrodes with LecTec LT 4900 gel Regulation Number: 21 CFR 870.2360 Regulation Name: Electrocardiograph Electrode Regulatory Class: Class II (two) Product Code: DRX Dated: November 21, 2002 Received: November 25, 2002
Dear Ms. Duncan:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
3
Page 2 - Ms. Elaine Duncan
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (301) 594-4646. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97) you may obtain. Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html
Sincerely yours,
N. Dale Tuth
ram D. Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
4
510(k) Number (if known)
K0239220.
Device Name:
Skintact ECG Tab Electrodes
Indications for Use:
Skintact ECG electrodes are designed for use in general electrocardiographic procedures where ECG monitoring is deemed necessary and is ordered by a physician. Such procedures include in particular, patient ECG surveillance and ECG diagnosis recording.
Skintact ECG electrodes are non-sterile and are to be used on intact (uninjured) skin.
(Please Do Not Write Below This Line-Continue On Another Page If Needed) Concurrence of CDRH, Office of Device Evaluation (ODE)
Prescription Use
OR
Over -The-Counter Use ________________________________________________________________________________________________________________________________________________________
(Optional Format 1-2-96)
Deretu
Division Si
510(k) Number K023420